Security key
005329107
Adagene Inc. - American Depository Receipt (ADAG)
CUSIP: 005329107
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / American Depository Receipt
- Shares outstanding
- 66,006,594
- Total 13F shares
- 5,722,260
- Share change
- -344,072
- Total reported value
- $11,251,842
- Price per share
- $1.99
- Number of holders
- 17
- Value change
- -$681,939
- Number of buys
- 5
- Number of sells
- 5
Report period
Q3 2025
Institutions
17
Top holders
10
ADAG full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Adagene Inc. SEC filings
Adagene Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 005329107
Recent filing periods:
Top shareholders of ADAG - Adagene Inc. - American Depository Receipt (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Peter Luo |
13D/G
|
HAN 2020 Irrevocable Trust |
16%
|
9,175,439
|
$12,937,369 | $0 | 25 Jan 2025 | |
| WuXi PharmaTech Healthcare Fund I L.P. |
13D/G
|
— |
7%
|
4,121,815
|
$8,187,161 | -$1,701,888 | 30 Sep 2025 | |
| Panacea Innovation Ltd |
13D/G
|
Panacea Venture Healthcare Fund II, L.P. |
3.8%
|
2,250,000
|
$4,469,175 | -$1,564,211 | 30 Sep 2025 | |
| FIL Ltd |
13D/G
|
FIL Limited |
1.8%
|
936,810
|
$1,320,902 | -$4,450,930 | 31 Mar 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
0.9%
|
473,949
|
$933,679 | $0 | 30 Jun 2025 | |
| GENERAL ATLANTIC, L.P. |
13F
|
Company |
5.8%
|
3,825,952
|
$7,460,606 | — | 30 Jun 2025 | |
| HSG Holding Ltd |
13F
|
Company |
2%
|
1,343,364
|
$2,619,560 | — | 30 Jun 2025 | |
| Mill Creek Capital Advisors, LLC |
13F
|
Company |
0.3%
|
199,610
|
$389,240 | — | 30 Jun 2025 | |
| Kamunting Street Capital Management, L.P. |
13F
|
Company |
0.19%
|
126,032
|
$245,762 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.12%
|
77,238
|
$150,614 | — | 30 Jun 2025 | |
| FIFTH LANE CAPITAL, LP |
13F
|
Company |
0.04%
|
27,500
|
$54,450 | — | 30 Jun 2025 | |
| Gordian Capital Singapore Pte Ltd |
13F
|
Company |
0.04%
|
24,000
|
$46,800 | — | 30 Jun 2025 | |
| Marex Group plc |
13F
|
Company |
0.04%
|
24,000
|
$46,800 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.03%
|
16,850
|
$33,000 | — | 30 Jun 2025 | |
| EverSource Wealth Advisors, LLC |
13F
|
Company |
0.02%
|
11,307
|
$22,049 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
10,309
|
$20,411 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0%
|
635
|
$1,238 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
400
|
$792 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
76
|
$148 | — | 30 Jun 2025 |
Institutional Holders of Adagene Inc. - American Depository Receipt (ADAG) as of Q3 2025
As of 30 Sep 2025,
Adagene Inc. - American Depository Receipt (ADAG) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,722,260 shares.
The largest 10 holders included
GENERAL ATLANTIC, L.P., HSG Holding Ltd, Mill Creek Capital Advisors, LLC, Kamunting Street Capital Management, L.P., MORGAN STANLEY, Gordian Capital Singapore Pte Ltd, CITADEL ADVISORS LLC, FIFTH LANE CAPITAL, LP, Marex Group plc, and ROYAL BANK OF CANADA.
This page lists
17
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
15
Q3 2025 holders
17
Holder diff
2
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.